Skip to main content
. 2005 Apr;59(4):433–439. doi: 10.1111/j.1365-2125.2004.02323.x

Figure 2.

Figure 2

Individual area under the concentration-time curve (AUC(0–∞)) values of R- and S-warfarin in 10 subjects after ingestion of 10 mg racemic warfarin during the placebo and gemfibrozil phases. Cross-over treatment sequences: placebo-gemfibrozil (open symbols), gemfibrozil-placebo (solid symbols)